Skinhealth Systems Inc (SKIN) 13F Filing Data & Analysis (Q2 2026)

SKIN ranks #4650 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

SKIN is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

98 institutions disclose a position in SKIN, but none treat it as a major bet — even Capricorn Fund Managers Ltd, its most concentrated holder, allocates just 1.2% of its own portfolio to it.

IFP Advisors, Inc has added to its SKIN position for two straight quarters, increasing it by $233.0 to reach $453.0 today.

Fidelity has trimmed its SKIN position for two straight quarters, cutting it by $18.3M while still holding $7.1M.

SKIN is down 0.1% today, and institutions have been net sellers of $5.3M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

SKIN reported a net loss of $28.4M over the trailing twelve months.

• Not yet profitable — net loss of $28.4M over the trailing twelve months
• Revenue declined 6.5% year over year
• Net income declined year over year, from -$19.0M to -$28.4M
• Generated $37.5M in positive operating cash flow
• Current ratio of 1.66x — enough short-term assets to cover short-term liabilities
• Liabilities run 7.19x equity — a highly leveraged balance sheet worth noting